| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44e0905262f429c7590b40df8448c0c5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
| filingDate |
2008-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_092dbd99a0067d8514733d2b9b6bfd21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_033e0f9d648015d3d4271760c3a34173 |
| publicationDate |
2008-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008261934-A1 |
| titleOfInvention |
Dosage Form for Hormonal Contraception |
| abstract |
A dosage form for hormonal contraception containing a specific number of gestagen-containing daily units A and a specific number of gestagen-containing daily units B for uninterrupted, daily, oral administration of daily units A and then immediately subsequently of daily units B, wherein the daily units A in each case contain at most 200 μg of folic acid and the daily units B contain >200 μg up to the maximum permissible amount of folic acid for women. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11679114-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-029329-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8741818-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009283269-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2730284-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014072245-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8476203-B2 |
| priorityDate |
2005-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |